Description

(6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanal is a high-purity steroid derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical chiral intermediate for the synthesis of complex bioactive molecules, offering precise stereochemical control. It is essential for researchers and manufacturers in the pharmaceutical and fine chemical sectors developing novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key chiral building block for the synthesis of steroidal drugs and hormone analogs.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new active pharmaceutical ingredients (APIs).
• Biochemical Research: Serves as a precursor or reference standard in studies involving steroid receptors and metabolic pathways.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to construct complex molecular architectures with specific stereocenters.
• Process Development: Used for scaling up and optimizing synthetic routes to steroidal compounds under cGMP conditions.

Basic Information

Product Name	(6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanal
CAS No.	3836-01-9
Molecular Formula	C27H44O4
Molecular Weight	432.64 g/mol
Synonyms	17β-[(1R)-1-Methyl-5-oxoheptyl]androstane-3β,7β,12α-triol; 3β,7β,12α-Trihydroxy-5β-cholan-24-al; 3β,7β,12α-Trihydroxy-5β-cholan-24-oic aldehyde; 5β-Cholan-24-al-3β,7β,12α-triol; A key intermediate for Chenodeoxycholic Acid synthesis; Steroidal aldehyde intermediate; (6R)-2-Methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanal
EINECS	Contact for details

Quality Control

Our (6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanal is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including chiral purity and impurity profiling, to ensure it meets the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) detailing identity, purity, and related substances are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Chiral Purity	≥ 99.0% de
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.